Adam Sharp

9PUBLICATIONS

136CO-AUTHORS

Molecular targetsTumour immunologyPredictive and prognostic markersCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|May 13, 2026

Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities.

|Apr 27, 2026

Phase I trial of Ipatasertib plus Atezolizumab enhances PI3K/AKT pathway immune responses in solid tumors and refractory glioblastoma.

|Oct 08, 2025

Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

|Jan 09, 2025

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer Growth.

Jonathan Welti, Denisa Bogdan, Ines Figueiredo

|Sep 12, 2024

AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer.

Sumaira Sardar, Christopher M McNair, Lakshmi Ravindranath

|Feb 27, 2024

Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate Cancer.

Antje Neeb, Ines Figueiredo, Denisa Bogdan

Pageof 2

Frequent Collaborators

Johann S de Bono

Wei Yuan

Bora Gurel

Denisa Bogdan

Ines Figueiredo

Mateus Crespo

Antje Neeb

Suzanne Carreira

Susana Miranda

Ana Ferreira

Frequent Collaborators

Johann S de Bono

Wei Yuan

Bora Gurel

Denisa Bogdan